PROVIDER PROFILE · NPI 1780716662

Emily SzmuilowiczM.D.

EndocrinologyChicago, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

545

Unique beneficiaries

—

Total services

861

Distinct HCPCS

Medicare payment

$53K

Peer benchmark

Total Medicare services vs. 262 Endocrinology providers in IL — above median (cohort median 1,061).

PRESCRIBING · PART D · 2024

Total Rx claims

890

Beneficiaries

—

Total drug cost

$538K

Distinct drugs

Brand share

68.7%

Top prescribed drugs

Levothyroxine Sodium172 claims

Tirzepatide99 claims

Levothyroxine Sodium93 claims

Semaglutide90 claims

Empagliflozin61 claims

QUALITY · MIPS · 2024

Final MIPS score

95.2

Quality

83.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.85%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Emily Szmuilowicz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NORTHWESTERN MEMORIAL HEALTHCARE	260	1,128
ENDEAVOR HEALTH CLINICAL OPERATIONS	46	147
NORTHWESTERN LAKE FOREST HOSPITAL	36	118
Erica Klaw Physician Assistant · Chicago, IL	22	31
REHABILITATION INSTITUTE OF CHICAGO	21	45
DAVISON, RICHARDO	13	22
Eric Hart Diagnostic Radiology · Chicago, IL	11	28
Rishi Agrawal Diagnostic Radiology · Houston, TX	11	20

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history